Skin Inflammation clinical trials

Explore recruiting skin inflammation clinical trials.

Recruiting skin inflammation studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Skin Inflammation trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Examination of medication-induced skin inflammation models and their use in the study of antibiotic concentration in inflamed, infected, and healthy subcutaneous tissue

Austria

Human Pharmacology (Phase I)- Other EU CTIS Study details

PIMOC - Personalized targeted therapies in inflammatory complex multi organ disease

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A bioequivalence vasoconstriction study comparing two clobetasol propionate 0.5 mg/g ointments after skin application in healthy adult human subjects

Poland

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

A Phase 2a, Multicenter, Randomized, Double-blind, Placebo-controlled Study of NAV-240 in Adult Participants with Moderate-to-Severe Hidradenitis Suppurativa

Hungary, Poland, Germany, Bulgaria, Romania

Therapeutic exploratory (Phase II) EU CTIS Study details

Treatment of KeratolytTreatment of Keratolytic Winter Erythema with systemic nitroxoline, a phase 2a randomized placebo controlled crossover study of male and female adults from three Norwegian familiesic Winter Erythema with systemic Nitroxoline, a phase 2a randomized placebo controlled cross-over study of male and female adults from three Norwegian families.

Norway

Therapeutic exploratory (Phase II) EU CTIS Study details

Skin Inflammation trials by city

Skin Inflammation in Toronto Skin Inflammation in Vancouver Skin Inflammation in Montreal Skin Inflammation in Calgary Skin Inflammation in Edmonton Skin Inflammation in Ottawa Skin Inflammation in Winnipeg Skin Inflammation in Quebec City Skin Inflammation in Hamilton Skin Inflammation in Kitchener Skin Inflammation in London Skin Inflammation in Halifax Skin Inflammation in New York Skin Inflammation in Los Angeles Skin Inflammation in Chicago Skin Inflammation in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease